English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

to the editor: Establishing new therapeutic approaches for patients with heart failure (HF) is of crucial importance. In a recent article from Science Translational Medicine , Duan et al. ([1][1]) demonstrated that bromodomain and extra-terminal motif (BET) bromodomain inhibitor JQ1 could treat HF

Letter to the editor: BET inhibitors might target innate inflammatory and profibrotic signaling networks in COPD